JOHN CUSTER: Open Payments
NPI 1578679452 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 28 payments from 9 companies in 2025. Trend: 2023 $1,049 · 2024 $644 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $177 |
| E.R. Squibb & Sons, L.L.C. | 5 | $117 |
| ABBVIE INC. | 4 | $65 |
| Alkermes, Inc. | 3 | $58 |
| Noven Therapeutics, LLC | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: COBENFY, AUSTEDO XR, VRAYLAR, ARISTADA, UZEDY, Xelstrym, Qelbree, ABILIFY ASIMTUFII.
Industry payments across SC — which companies pay providers there.
